0

Endocrine and Metabolism Collection
 261-280 of 2381 Articles
Articles |  3 December 2002
Significant Differential Effects of Alendronate, Estrogen, or Combination Therapy on the Rate of Bone Loss after Discontinuation of Treatment of Postmenopausal Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Susan L. Greenspan, MD; Ronald D. Emkey, MD; Henry G. Bone, MD; et al.
Ann Intern Med. 2002;137(11):875-883. doi:10.7326/0003-4819-137-11-200212030-00008
Reviews |  3 December 2002
Effects of Subclinical Thyroid Dysfunction on the Heart
Bernadette Biondi, MD; Emiliano A. Palmieri, MD; Gaetano Lombardi, MD; et al.
Ann Intern Med. 2002;137(11):904-914. doi:10.7326/0003-4819-137-11-200212030-00011
Ideas and Opinions |  1 October 2002
In Memoriam: J. Russell Elkinton, MD, MACP, FRCP(L); 1910–2002; Editor, Annals of Internal Medicine, 1960–1971
Edward J. Huth, MD, Editor Emeritus
Ann Intern Med. 2002;137(7):613-614. doi:10.7326/0003-4819-137-7-200210010-00013
Academia and the Profession |  20 August 2002
Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
R Graham Barr, MD, MPH; David M. Nathan, MD; James B. Meigs, MD, MPH; et al.
Ann Intern Med. 2002;137(4):263-272. doi:10.7326/0003-4819-137-4-200208200-00011
Editorials |  20 August 2002
Articles on Diagnostic Tests: A New Series and an Invitation to Authors
Alan M. Garber, MD, PhD; Cynthia Mulrow, MD, MPH, Deputy Editor; Harold C. Sox, MD, Editor
Ann Intern Med. 2002;137(4):288-289. doi:10.7326/0003-4819-137-4-200208200-00014
Academia and the Profession |  16 July 2002 FREE
Unexpected Hypoglycemia in a Critically Ill Patient
David W. Bates, MD, MSc*
Ann Intern Med. 2002;137(2):110-116. doi:10.7326/0003-4819-137-2-200207160-00009
Brief Communications |  21 May 2002
Alendronate Improves Bone Mineral Density in Elderly Women with Osteoporosis Residing in Long-Term Care Facilities: A Randomized, Double-Blind, Placebo-Controlled Trial
Susan L. Greenspan, MD; Diane L. Schneider, MD; Michael R. McClung, MD; et al.
Ann Intern Med. 2002;136(10):742-746. doi:10.7326/0003-4819-136-10-200205210-00009
Therapeutics |  May/Jun 2002
Review: Etidronate decreases vertebral but not nonvertebral fractures in postmenopausal women
Sophie Jamal, MD
Ann Intern Med. 2002;136(3):98. doi:10.7326/ACPJC-2002-136-3-098
Therapeutics |  May/Jun 2002
Review: Exercise training reduces HbA1c levels but not body mass in type 2 diabetes mellitus
Paul Franks, MSc, MPhil; Simon Griffin, MSc, DM, MRCGP
Ann Intern Med. 2002;136(3):100. doi:10.7326/ACPJC-2002-136-3-100
Therapeutics |  May/Jun 2002
Overall satisfaction increased more with inhaled insulin than with subcutaneous insulin in type 1 diabetes
Rudy Bilous, MD
Ann Intern Med. 2002;136(3):101. doi:10.7326/ACPJC-2002-136-3-101
Prognosis |  May/Jun 2002
Review: Stress hyperglycemia after ischemic stroke indicates a greater risk for death in patients without diabetes
James Douketis, MD
Ann Intern Med. 2002;136(3):114. doi:10.7326/ACPJC-2002-136-3-114
Clinical Prediction Guide |  May/Jun 2002
Several simple rules predicted complications in high-risk patients with diabetes
Steven Smith, MD
Ann Intern Med. 2002;136(3):117. doi:10.7326/ACPJC-2002-136-3-117
Therapeutics |  May/Jun 2002
Intensive insulin therapy reduced mortality and morbidity in critically ill patients
Daniel L. Hurley, MD; M. Molly McMahon, MD
Ann Intern Med. 2002;136(3):81. doi:10.7326/ACPJC-2002-136-3-081
Therapeutics |  May/Jun 2002
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):82. doi:10.7326/ACPJC-2002-136-3-082
Therapeutics |  May/Jun 2002
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):83. doi:10.7326/ACPJC-2002-136-3-083
Therapeutics |  May/Jun 2002
Losartan was renoprotective in diabetic nephropathy independent of its effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):84. doi:10.7326/ACPJC-2002-136-3-084
Articles |  16 April 2002 FREE
A Diabetes Report Card for the United States: Quality of Care in the 1990s
Jinan B. Saaddine, MD; Michael M. Engelgau, MD; Gloria L. Beckles, MD; et al.
Ann Intern Med. 2002;136(8):565-574. doi:10.7326/0003-4819-136-8-200204160-00005
Articles |  16 April 2002
Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?
Michael P. Stern, MD; Ken Williams, MS; Steven M. Haffner, MD, MPH
Ann Intern Med. 2002;136(8):575-581. doi:10.7326/0003-4819-136-8-200204160-00006
Articles |  2 April 2002
Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control: A Randomized, Controlled Trial
Carmine G. Fanelli, MD, PhD; Simone Pampanelli, MD; Francesca Porcellati, MD, PhD; et al.
Ann Intern Med. 2002;136(7):504-514. doi:10.7326/0003-4819-136-7-200204020-00007
Editorials |  2 April 2002
Avoiding Nocturnal Hypoglycemia: Consideration of an Extra Injection at Bedtime
Andrew W. Norris, MD, PhD; Lori M.B. Laffel, MD, MPH
Ann Intern Med. 2002;136(7):547-549. doi:10.7326/0003-4819-136-7-200204020-00013
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)